South Korea · Delayed Price · Currency is KRW Cellumed Statistics
Total Valuation
Cellumed has a market cap or net worth of KRW 83.94 billion. The enterprise value is 91.55 billion.
| Market Cap | 83.94B |
| Enterprise Value | 91.55B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellumed has 83.19 million shares outstanding. The number of shares has increased by 18.52% in one year.
| Current Share Class | 83.19M |
| Shares Outstanding | 83.19M |
| Shares Change (YoY) | +18.52% |
| Shares Change (QoQ) | +42.56% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 1.51% |
| Float | 45.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.67 |
| PB Ratio | 3.51 |
| P/TBV Ratio | 3.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.26 |
| Quick Ratio | 0.64 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.69 |
| Interest Coverage | -5.92 |
Financial Efficiency
Return on equity (ROE) is -13.77% and return on invested capital (ROIC) is -35.43%.
| Return on Equity (ROE) | -13.77% |
| Return on Assets (ROA) | -4.78% |
| Return on Invested Capital (ROIC) | -35.43% |
| Return on Capital Employed (ROCE) | -21.17% |
| Weighted Average Cost of Capital (WACC) | 10.86% |
| Revenue Per Employee | 1.38B |
| Profits Per Employee | -27.23M |
| Employee Count | 90 |
| Asset Turnover | 1.73 |
| Inventory Turnover | 16.32 |
Taxes
| Income Tax | -38.78M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.93% in the last 52 weeks. The beta is 1.30, so Cellumed's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | -29.93% |
| 50-Day Moving Average | 1,532.94 |
| 200-Day Moving Average | 991.65 |
| Relative Strength Index (RSI) | 39.32 |
| Average Volume (20 Days) | 1,769,414 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cellumed had revenue of KRW 124.37 billion and -2.45 billion in losses. Loss per share was -40.78.
| Revenue | 124.37B |
| Gross Profit | 6.62B |
| Operating Income | -5.49B |
| Pretax Income | -2.56B |
| Net Income | -2.45B |
| EBITDA | -4.79B |
| EBIT | -5.49B |
| Loss Per Share | -40.78 |
Balance Sheet
The company has 17.24 billion in cash and 10.93 billion in debt, with a net cash position of 6.31 billion or 75.84 per share.
| Cash & Cash Equivalents | 17.24B |
| Total Debt | 10.93B |
| Net Cash | 6.31B |
| Net Cash Per Share | 75.84 |
| Equity (Book Value) | 23.89B |
| Book Value Per Share | 287.16 |
| Working Capital | 10.88B |
Cash Flow
In the last 12 months, operating cash flow was -6.37 billion and capital expenditures -81.07 million, giving a free cash flow of -6.45 billion.
| Operating Cash Flow | -6.37B |
| Capital Expenditures | -81.07M |
| Depreciation & Amortization | 706.63M |
| Net Borrowing | 2.72B |
| Free Cash Flow | -6.45B |
| FCF Per Share | -77.53 |
Margins
Gross margin is 5.33%, with operating and profit margins of -4.42% and -1.97%.
| Gross Margin | 5.33% |
| Operating Margin | -4.42% |
| Pretax Margin | -2.06% |
| Profit Margin | -1.97% |
| EBITDA Margin | -3.85% |
| EBIT Margin | -4.42% |
| FCF Margin | n/a |
Dividends & Yields
Cellumed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.52% |
| Shareholder Yield | -18.52% |
| Earnings Yield | -2.92% |
| FCF Yield | -7.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 28, 2017. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 28, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Cellumed has an Altman Z-Score of -0.43 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.43 |
| Piotroski F-Score | 1 |